超基因医药 RARE
$15.43 −$0.14 (-0.90%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.43 0.00%
开盘$15.68
昨收$15.57
当日区间$15.12 – $15.97
成交量4.05M
市值$1.57B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例117.9%+7.41 个百分点，较上季度
持仓机构数379-8 ，较上季度
内部人近期交易30次买入 / 20次卖出净买入
空头持仓比例20.43% 占流通股回补天数 5.2 · 截至 15 Oct 2026
卖空成交量占比12.9%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$3.66M（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有38.7%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从15.19%升至20.43%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Madison Avenue Partners, LP | Hedge Fund | 2026/Q3 | +6,307,798 | 6.4% |
| Scout Investments, Inc. | Mutual Fund | 2026/Q3 | +743,419 | 0.8% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +4,148,100 | 7.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,354,678 | 10.8% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +1,972,711 | 6.6% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +1,508,648 | 3.0% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +1,418,215 | 1.4% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +1,415,380 | 3.7% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,404,143 | 6.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,137,325 | 6.3% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,100,000 | 1.6% |
| Jefferies Financial Group Inc. | Public Company | 2026/Q3 | +914,138 | 0.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +729,437 | 2.6% |
| Frontier Capital Management | Mutual Fund | 2026/Q3 | +656,754 | 2.9% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +586,230 | 0.6% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -7,066 | $15.27 | 13,026 |
| 14 Sep 2026 | Theodore Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer | Open Market Disposition | -1,283 | $13.57 | 30,856 |
| 2 Sep 2026 | Theodore Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer | Open Market Disposition | -161 | $13.99 | 31,963 |
| 2 Aug 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,696 | $24.92 | 96,295 |
| 2 Aug 2026 | Karah Parschauer | Chief Legal Officer & Executive VP of Corporate Affairs | Open Market Disposition | -1,900 | $24.92 | 38,397 |
| 30 Jun 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,698 | $33.13 | 4,695 |
| 14 Jun 2026 | Corazon Sanders | Independent Director | Open Market Disposition | -2,000 | $25.05 | 13,344 |
| 14 Jun 2026 | Karah Parschauer | Chief Legal Officer & Executive VP of Corporate Affairs | Open Market Disposition | -1,899 | $24.62 | 40,297 |
| 31 May 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,653 | $23.77 | 9,392 |
| 17 May 2026 | Shehnaaz Suliman | Independent Director | Open Market Disposition | -5,740 | $25.12 | 20,200 |
| 13 May 2026 | Daniel Welch | Independent Non-Executive Chairperson | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Daniel Welch | Independent Non-Executive Chairperson | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Matthew Fust | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Matthew Fust | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Shehnaaz Suliman | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Shehnaaz Suliman | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Deborah Dunsire | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Deborah Dunsire | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Corazon Sanders | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Corazon Sanders | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 20,145,283 | 20.4% | 5.2 |
| 30 Sep 2026 | 20,349,877 | 20.6% | 3.1 |
| 15 Sep 2026 | 16,571,956 | 16.8% | 2.2 |
| 31 Aug 2026 | 17,144,354 | 17.4% | 8.0 |
| 14 Aug 2026 | 15,887,767 | 16.1% | 7.8 |
| 31 Jul 2026 | 14,963,396 | 15.2% | 8.3 |
暂无评论——快来第一个聊聊 RARE。
登录后参与讨论。